51 results
Page 2 of 3
20-F/A
akhj1w7z4q
23 Mar 15
Annual report (foreign) (amended)
12:00am
424B3
agce9
8 Aug 13
Prospectus supplement
12:00am
424B3
n09vm4skbn izz
15 Oct 12
Prospectus supplement
12:00am
F-1
8nhmank p5hn27e
2 Oct 12
Registration statement (foreign)
12:00am
424B3
j7ltt3 i66o9648iv
28 Mar 12
Prospectus supplement
12:00am
20-F
cl9nnjxal8v 60
22 Mar 12
Annual report (foreign)
12:00am
6-K
EX-99
ibg3n8tn8 ptr0
13 Dec 11
BioLineRx to Develop and Commercialize Novel Peptide
12:00am
6-K
EX-2
3pdpub 08
23 Aug 11
Condensed Consolidated Interim Financial Statements
12:00am
20FR12B/A
352 a48y7iwzw05
15 Jul 11
Initial registration of securities (foreign private issuers) (amended)
12:00am
20FR12B
EX-4.2
k1a6sv6mf47vx5qeol
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
20FR12B
EX-4.1
cj2hus1 l3t8lfxhx
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
20FR12B
EX-4.21
u0jougl4cf1yf
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
20FR12B
EX-4.3
c27ncsxxylmg3xof1
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
20FR12B
EX-4.5
wluqoe06j8lcum9v6u
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am